US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 25.720
  • +0.210+0.82%
Close Dec 2 16:00 ET
  • 26.480
  • +0.760+2.95%
Post 19:55 ET
92.28MMarket Cap-3547P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aligos Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
333.33K
1.27M
+935.67K
Beat Est.
-89.71%
-60.82%
+280.70%
EPS
-1.72
-3.07
-1.35
Miss Est.
+83.25%
+70.40%
-78.84%
Analyst Rating
Buy

Dec 2, 2024

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

  • Aligos Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:28 ET

  • Aligos Therapeutics | 8-K: Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

    Nov 6 16:09 ET

  • Aligos Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:21 ET

  • Aligos Therapeutics | 8-K: Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

    Aug 6 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 2, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-4.49%